Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R44DK103377)
Received: 2 October 2017
Accepted: 13 April 2018
First Online: 19 April 2018
Compliance with ethical standards
: Dr. James R. Hébert owns controlling interest in Connecting Health Innovations LLC (CHI), a company planning to license the right to his invention of the dietary inflammatory index (DII) from the University of South Carolina in order to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings. Drs. Nitin Shivappa and Michael Wirth are employees of CHI.